2098546-05-3
2098546-05-3
Chemical Structure
EBI-2511
- CAS No.: 2098546-05-3
- Formula:C34H48N4O4
- Molecular Weight:576.77
IUPAC Name: N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-ethyl-6-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-2-(1-isopropylpiperidin-4-yl)benzofuran-4-carboxamide
InChIKey: NYWVSLBALKNFJR-UHFFFAOYSA-N
SMILES: CCC1=C(C(NCC2=C(C)C=C(C)NC2=O)=O)C(C=C(C3CCN(C(C)C)CC3)O4)=C4C=C1N(C5CCOCC5)CC
Biological Activity: EBI-2511 is a highly potent and orally active EZH2 inhibitor, with an IC50 of 6 nM in Pfeffiera cell lines, respectively.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
EBI-2511 | 98.67% | EBI-2511 is a highly potent and orally active EZH2 inhibitor, with an IC50 of 6 nM in Pfeffiera cell lines, respectively. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
EBI-2511 (Standard) | ≥98% | EBI-2511 (Standard) is the analytical standard of EBI-2511 (HY-111418). This product is intended for research and analytical applications. EBI-2511 is a highly potent and orally active EZH2 inhibitor, with an IC50 of 6 nM in Pfeffiera cell lines, respectively. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 0.80
HY-153191Zeprumetostat -
Similarity Score 0.61
HY-13803RTazemetostat (Standard) -
Similarity Score 0.61
HY-147230EZH2-IN-13 -
Similarity Score 0.60
HY-156615Igermetostat -
Similarity Score 0.60
HY-149726EZH2-IN-17 -
Similarity Score 0.58
HY-179351EZH2 ligand-1 -
Similarity Score 0.58
HY-147091Tazemetostat de(methyl morpholine)-COOH -
Similarity Score 0.58
HY-786945-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-2-methylbenzamide -
Similarity Score 0.57
HY-177497SKLB-03220 -
Explore the MedChemAI to find more analogs
